DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Cauley JA, Norton L, Lippman ME. et al.
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Breast Cancer Res Treat 2001; 65: 125-134
We do not assume any responsibility for the contents of the web pages of other providers.